Latest Pulse oximetry Stories

IRVINE, Calif., Feb. 15, 2013 /PRNewswire/ -- Congenital Heart Defects (CHD) are the leading cause of infant deaths - affecting about 1 in 125 babies.(1,2) In the U.S., one in three infants with a potentially life-threatening CHD leaves the hospital undiagnosed.(3) Early detection through pulse oximetry screening and intervention are keys to saving the lives of babies with CHDs.(4) The screening determines the amount of oxygen in the blood and pulse rate. It is inexpensive,...

In the news release, Masimo Reports Fourth Quarter and Full Year 2012 Financial Results; Provides 2013 Financial Guidance, issued 14-Feb-2013 by Masimo Corporation over PR Newswire, we are advised by the company that in the table titled "CONSOLIDATED STATEMENTS OF INCOME," in the "Weighted average shares used in per share calculations: Diluted" section, under the Twelve Months Ended, December 29, 2012 column, the number should read "58,374" rather than "58,734" as originally issued...

IRVINE, Calif., Feb. 14, 2013 /PRNewswire/ -- Masimo (NASDAQ: MASI) today announced that its Board of Directors has authorized the repurchase of up to 6 million shares of the company's common stock. The stock repurchase program may be carried out at the direction of the company through open market purchases, block trades, one or more trading plans adopted in accordance with Rule 10b5-1 of the Securities and Exchange Commission, and in privately negotiated transactions. The repurchase...

IRVINE, Calif., Feb. 14, 2013 /PRNewswire/ -- Q4 2012 Highlights (compared to Q4 2011): Product revenue rose 20% to $125.3 million Masimo rainbow revenue rose 13% to $11.1 million Shipped 42,700 Masimo SET® and Masimo rainbow® SET units Net income was $15.0 million, with EPS of $0.26 versus $0.23 in the year-ago period Full Year 2012 Highlights (compared to 2011): Product revenue rose 14% to $464.9 million Masimo rainbow revenue rose 18% to $40.3 million Shipped...

MINNEAPOLIS, Jan. 31, 2013 /PRNewswire/ -- Nonin Medical, Inc., the inventor of finger pulse oximeters and a leader in noninvasive medical monitoring, announced today that the company has donated six Onyx(®) 9500 finger pulse oximeters to the Evangelistic International Ministries (EIM) for use at the Hospital Centro Socorro De Lo Alto in the remote village of Sula, Honduras. The Nonin Onyx 9500 is the world's first finger pulse oximeter with more than 1.1 million devices in use...

DUBAI, United Arab Emirates and IRVINE, Calif., Jan. 30, 2013 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that Libya has become the first country to begin using the Masimo Pronto-7(®)-- a handheld noninvasive hemoglobin spot-check device -- to screen potential blood donors for low hemoglobin level in all of its major blood-donation centers. The announcement comes at Arab Health, the world's longest-running healthcare exhibition and congress held each January in Dubai....

IRVINE, Calif., Jan. 30, 2013 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that it will release fourth quarter and full year 2012 financial results for the period ended December 29, 2012, after the market closes on Thursday, February 14, 2013. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad, Executive Vice President and Chief Financial Officer. A...

CHICAGO, Jan. 16, 2013 /PRNewswire/ -- CMS is now considering a new proposed quality measure (#3040) that calls for "appropriate monitoring of patients receiving PCA [patient-controlled analgesia]." Says Michael Wong, executive director of the Physician-Patient Alliance for Health & Safety (PPAHS), "At first glance, this seems to address a critical patient safety issue: opioid induced respiratory depression." In its Sentinel Event Alert No. 49, "Safe Use of Opioids in...

IRVINE, Calif., Jan. 11, 2013 /PRNewswire/ -- A new study using Masimo (NASDAQ: MASI) noninvasive and continuous total hemoglobin (SpHb) monitoring technology has received the 2013 Best Clinical Application of Technology Award at the Society for Technology in Anesthesia (STA) Annual Meeting. The winning study, "Reduction in Red Blood Cell Transfusions during Neurosurgery with Noninvasive and Continuous Hemoglobin Monitoring" evaluated the use of SpHb monitoring in patients...

IRVINE, Calif., Jan. 10, 2013 /PRNewswire/ -- Noninvasive and continuous total hemoglobin (SpHb) monitoring technology from Masimo (NASDAQ: MASI) helps clinicians reduce intra-operative red blood cell (RBC) transfusions during high blood-loss surgery, speeds time to transfusion when indicated, and saves significant costs, according to a new study unveiled at the Society for Technology in Anesthesia (STA) annual meeting.(1) The study was one of just five receiving the distinguished...